309 related articles for article (PubMed ID: 37747559)
21. An update on genetic aberrations in T-cell neoplasms.
Parilla M; Quesada AE; Medeiros LJ; Thakral B
Pathology; 2023 Apr; 55(3):287-301. PubMed ID: 36801152
[TBL] [Abstract][Full Text] [Related]
22. Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.
Campo E
Mod Pathol; 2013 Jan; 26 Suppl 1():S97-S110. PubMed ID: 23281439
[TBL] [Abstract][Full Text] [Related]
23. Molecular Pathology of Mature Lymphoid Malignancies.
Ware AD; Davis K; Xian RR
Clin Lab Med; 2024 Jun; 44(2):355-376. PubMed ID: 38821649
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Lefebvre C; Callet-Bauchu E; Chapiro E; Nadal N; Penther D; Poirel HA
Ann Biol Clin (Paris); 2016 Oct; 74(5):568-587. PubMed ID: 27707672
[TBL] [Abstract][Full Text] [Related]
25. DNA microarrays in lymphoid malignancies.
Rosenwald A
Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
[TBL] [Abstract][Full Text] [Related]
26. New insights into the diagnosis of lymphomas.
Soldini D; Campo E
Ann Oncol; 2012 Sep; 23 Suppl 10():x83-8. PubMed ID: 22987998
[TBL] [Abstract][Full Text] [Related]
27. Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives.
Jeon YK; Yoon SO; Paik JH; Kim YA; Shin BK; Kim HJ; Cha HJ; Kim JE; Huh J; Ko YH; ;
J Pathol Transl Med; 2017 May; 51(3):224-241. PubMed ID: 28535584
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnosis of lymphoid malignancies by gene expression profiling.
Davis RE; Staudt LM
Curr Opin Hematol; 2002 Jul; 9(4):333-8. PubMed ID: 12042708
[TBL] [Abstract][Full Text] [Related]
29. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
30. Hematopathology approaches to diagnosis and prognosis of indolent B-cell lymphomas.
Gascoyne RD
Hematology Am Soc Hematol Educ Program; 2005; ():299-306. PubMed ID: 16304395
[TBL] [Abstract][Full Text] [Related]
31. [New trends and novel possibilities in the diagnosis of lymphomas].
Illés Á; Simon Z
Magy Onkol; 2015 Mar; 59(1):73-8. PubMed ID: 25763917
[TBL] [Abstract][Full Text] [Related]
32. Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience.
Pillonel V; Juskevicius D; Bihl M; Stenner F; Halter JP; Dirnhofer S; Tzankov A
Leuk Lymphoma; 2020 Nov; 61(11):2568-2583. PubMed ID: 32623938
[TBL] [Abstract][Full Text] [Related]
33. Overview of the role of molecular methods in the diagnosis of malignant lymphomas.
Medeiros LJ; Carr J
Arch Pathol Lab Med; 1999 Dec; 123(12):1189-207. PubMed ID: 10583924
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications.
Dunphy CH
Arch Pathol Lab Med; 2006 Apr; 130(4):483-520. PubMed ID: 16594743
[TBL] [Abstract][Full Text] [Related]
35. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
van Krieken JH; Langerak AW; Macintyre EA; Kneba M; Hodges E; Sanz RG; Morgan GJ; Parreira A; Molina TJ; Cabeçadas J; Gaulard P; Jasani B; Garcia JF; Ott M; Hannsmann ML; Berger F; Hummel M; Davi F; Brüggemann M; Lavender FL; Schuuring E; Evans PA; White H; Salles G; Groenen PJ; Gameiro P; Pott Ch; Dongen JJ
Leukemia; 2007 Feb; 21(2):201-6. PubMed ID: 17170732
[TBL] [Abstract][Full Text] [Related]
36. Cytogenomics of B-cell non-Hodgkin lymphomas: The "old" meets the "new".
Grau M; López C; Martín-Subero JI; Beà S
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101513. PubMed ID: 38092483
[TBL] [Abstract][Full Text] [Related]
37. Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
Bailey NG; Elenitoba-Johnson KSJ
Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31932467
[TBL] [Abstract][Full Text] [Related]
38. [Classification of malignant lymphomas. Current situation].
Koch K; Klapper W
Internist (Berl); 2016 Mar; 57(3):206-13. PubMed ID: 26800678
[TBL] [Abstract][Full Text] [Related]
39. [Genetic dissection of the molecular mechanism of malignant lymphoma using advanced genomic technology].
Shingaki S; Kataoka K
Rinsho Ketsueki; 2022; 63(9):1058-1066. PubMed ID: 36198530
[TBL] [Abstract][Full Text] [Related]
40. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
